L. Cusan

5.6k total citations · 1 hit paper
85 papers, 4.1k citations indexed

About

L. Cusan is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, L. Cusan has authored 85 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 37 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Molecular Biology. Recurrent topics in L. Cusan's work include Prostate Cancer Treatment and Research (36 papers), Hormonal and reproductive studies (29 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). L. Cusan is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Hormonal and reproductive studies (29 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). L. Cusan collaborates with scholars based in Canada, Russia and United States. L. Cusan's co-authors include Fernand Labrie, Alain Bélanger, Bernard Candas, José‐Luis Gomez, P. Diamond, A. Bèlanger, André Dupont, A. Dupont, Paul A. Kelly and C. Auclair and has published in prestigious journals such as Nature, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

L. Cusan

83 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging

1997 552 citations Fernand Labrie, Alain Bélanger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Cusan Canada	33	2.0k	1.2k	931	878	793	85	4.1k
A. Bèlanger Canada	36	2.7k 1.3×	1.4k 1.1×	822 0.9×	1.4k 1.5×	1.4k 1.8×	137	5.1k
André Dupont Canada	36	1.5k 0.7×	1.1k 0.9×	682 0.7×	1.1k 1.2×	438 0.6×	72	4.1k
Reijo Vihko Finland	40	1.6k 0.8×	483 0.4×	962 1.0×	1.1k 1.2×	1.6k 2.0×	99	4.2k
IONE A. KOURIDES United States	37	2.7k 1.3×	420 0.3×	637 0.7×	824 0.9×	535 0.7×	78	4.1k
A. Dupont Canada	26	1.1k 0.5×	785 0.6×	311 0.3×	461 0.5×	384 0.5×	50	2.3k
Marcella Motta Italy	28	574 0.3×	401 0.3×	504 0.5×	679 0.8×	474 0.6×	66	2.2k
Gavin P. Vinson United Kingdom	36	1.8k 0.9×	173 0.1×	314 0.3×	1.4k 1.6×	671 0.8×	158	4.2k
Brett T. Marck United States	27	825 0.4×	1.1k 0.9×	188 0.2×	951 1.1×	475 0.6×	53	3.1k
Sonia Dupont Belgium	17	914 0.5×	269 0.2×	370 0.4×	949 1.1×	1.9k 2.3×	31	3.4k
Justo P. Castaño Spain	46	2.1k 1.0×	262 0.2×	951 1.0×	2.3k 2.6×	404 0.5×	250	6.8k

Countries citing papers authored by L. Cusan

Since Specialization

Citations

This map shows the geographic impact of L. Cusan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cusan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cusan more than expected).

Fields of papers citing papers by L. Cusan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Cusan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cusan. The network helps show where L. Cusan may publish in the future.

Co-authorship network of co-authors of L. Cusan

This figure shows the co-authorship network connecting the top 25 collaborators of L. Cusan. A scholar is included among the top collaborators of L. Cusan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Cusan. L. Cusan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Labrie, Fernand, A. Bèlanger, Claude Labrie, et al.. (2007). Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 107(1-2). 57–69. 30 indexed citations

Labrie, Fernand, et al.. (1999). Long-Term Combined Androgen Blockade Alone for Localized Prostate Cancer.. PubMed. 3(3). 217–226. 30 indexed citations

Grégoire, Jean‐Pierre, et al.. (1996). [Validation of a French adaptation of the international prostatic symptom score].. PubMed. 6(2). 240–9. 17 indexed citations

Labrie, Fernand, A. Bèlanger, L. Cusan, et al.. (1996). History of LHRH agonist and combination therapy in prostate cancer. Endocrine Related Cancer. 3(3). 243–278. 39 indexed citations

Diamond, P., L. Cusan, José L. Gómez, A. Bélanger, & Fernand Labrie. (1996). Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.. PubMed. 150 Suppl. S43–50. 91 indexed citations

Diamond, P., et al.. (1996). F099 metabolic effects of 12-month percutaneous DHEA replacement therapy in postmenopausal women. Maturitas. 27. 73–73. 8 indexed citations

Cusan, L.. (1994). Prostate cancer screening with PSA, DRE and TRUS.. PubMed. 4 Suppl 1. 63–4. 2 indexed citations

Labrie, Fernand, A Dupont, L. Cusan, et al.. (1993). Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.. PubMed. 16(6). 499–509. 97 indexed citations

Bélanger, Alain, et al.. (1989). Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men. Journal of Steroid Biochemistry. 32(5). 695–698. 183 indexed citations

10.

Bèlanger, A., Fernand Labrie, A Dupont, M. Brochu, & L. Cusan. (1988). Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.. PubMed. 11(5). 321–6. 19 indexed citations

11.

Brochu, M., Alain Bélanger, André Dupont, L. Cusan, & Fernand Labrie. (1987). Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. Journal of Steroid Biochemistry. 28(6). 619–622. 38 indexed citations

12.

Labrie, Fernand, L. Cusan, Isabel A Lüthy, et al.. (1987). Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience. Cancer and Metastasis Reviews. 6(4). 615–636. 4 indexed citations

13.

Gordeladze, Jan O., Thomas Åbyholm, L. Cusan, O. P. F. Clausen, & V. Hansson. (1982). Cellular Localization of the Mn²⁺-Dependent Adenylyl Cyclase in the Human Testis. Archives of Andrology. 8(3). 199–204. 14 indexed citations

14.

Bèlanger, A., L. Cusan, C. Auclair, et al.. (1980). Effect of an LHRH Agonist and hCG on Testicular Steroidogenesis in the Adult Rat. Biology of Reproduction. 22(5). 1094–1101. 32 indexed citations

15.

Labrie, Fernand, L. Cusan, Carl Séguin, et al.. (1980). Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.. PubMed. 25(3). 157–70. 40 indexed citations

16.

Dupont, A., Nicholas Barden, L. Cusan, et al.. (1980). beta-Endorphin and met-enkephalins: their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control.. PubMed. 39(8). 2544–50. 66 indexed citations

17.

Cusan, L., C. Auclair, Alain Bélanger, et al.. (1979). Inhibitory Effects of Long Term Treatment with a Luteinizing Hormone-Releasing Hormone Agonist on the Pituitary-Gonadal Axis in Male and Female Rats. Endocrinology. 104(5). 1369–1376. 111 indexed citations

18.

Kledzik, G. S., L. Cusan, C. Auclair, Paul A. Kelly, & Fernand Labrie. (1978). Inhibitory Effect of a Luteinizing Hormone (LH)-Releasing Hormone Agonist on Rat Ovarian LH and Follicle-Stimulating Hormone Receptor Levels During Pregnancy. Fertility and Sterility. 29(5). 560–564. 65 indexed citations

19.

Kledzik, G. S., L. Cusan, C. Auclair, Paul A. Kelly, & Fernand Labrie. (1978). Inhibition of Ovarian Luteinizing Hormone (LH) and Follicle-Stimulating Hormone Receptor Levels With an LH-Releasing Hormone Agonist During the Estrous Cycle in the Rat. Fertility and Sterility. 30(3). 348–353. 49 indexed citations

20.

Dupont, André, et al.. (1977). Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues and. Life Sciences. 21(7). 907–914. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact